e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Cystic fibrosis: basic and applied science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MiR-145 and SMAD3 expression in patients with cystic fibrosis
F. Megiorni, S. Cialfi, G. Cimino, R. V. De Biase, D. Savi, C. Dominici, A. Pizzuti, S. Quattrucci (Rome, Italy)
Source:
Annual Congress 2013 –Cystic fibrosis: basic and applied science
Session:
Cystic fibrosis: basic and applied science
Session type:
Poster Discussion
Number:
2105
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Megiorni, S. Cialfi, G. Cimino, R. V. De Biase, D. Savi, C. Dominici, A. Pizzuti, S. Quattrucci (Rome, Italy). MiR-145 and SMAD3 expression in patients with cystic fibrosis. Eur Respir J 2013; 42: Suppl. 57, 2105
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Paul Bongaerts (Echt, Netherlands) - 07.09.2013 13:25
A difficult subject. It is very good that there is attention for this subject.
Wim Put (Vroenhoven, Belgium) - 07.09.2013 13:21
great
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Cystic fibrosis and intestinal organoids
Asbestosis
Related content which might interest you:
Mitophagic regulation of myofibroblast differentiation in lung fibroblasts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Immunoproteasome expression in pulmonary fibrosis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Molecular mechanisms of pirfenidone activity in human lung fibroblasts
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
The role of
Foxc2
gene in lung development
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
K
Ca
3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
The role of miR-21 and miR-34a in the fibrotic process of the lung
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Loss of CARM1 prolongs bleomycin-induced pulmonary fibrosis
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Increased levels of glycosaminoglycans in lungs from patients with IPF
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Polymorphisms in
NOS-1
and
NOS-3
genes may influence the cystic fibrosis severity?
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Role of MUC1 in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Genetic characterization of cystic fibrosis patients in Portugal
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept